Internal Medicine, Nephrology · Darby, PA
NPI
1912219312
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1501 Lansdowne Ave Ste 201
Darby, PA, 19023
Phone (610) 534-6230
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
1,251 services
Medicare patients, 2024
276
Average age 70
Drug cost, 2024
$98K
631 prescriptions
Company payments, 2025
$469
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit Deshpande was code 99232 (hospital e&m - subsequent), 312 times for 99 patients. In total Amit Deshpande billed 1,251 services in 19 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 312 | 99 | $62.86 | $20K |
| 90960 ESRD Related Services (not dialysis) | Office | 259 | 37 | $263.16 | $68K |
| 99214 Office E&M - Established | Office | 184 | 106 | $91.04 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 147 | 92 | $12.30 | $1,807 |
| 99233 Hospital E&M - Subsequent | Facility | 89 | 44 | $95.20 | $8,473 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 60 | 20 | $49.75 | $2,985 |
| 99223 Hospital E&M - Initial | Facility | 47 | 41 | $139.20 | $6,542 |
| 90961 ESRD Related Services (not dialysis) | Office | 43 | 31 | $215.87 | $9,282 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 43 | 20 | $39.21 | $1,686 |
| 99222 Hospital E&M - Initial | Facility | 35 | 28 | $102.35 | $3,582 |
By year: 2022 $137K for 977 services; 2023 $135K for 1,144 services; 2024 $142K for 1,251 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit Deshpande prescribed most often to Medicare patients was Calcitriol, with 72 prescriptions and refills. In total Amit Deshpande wrote 631 Medicare prescriptions that cost $98K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 72 | 117 | 14 | $956 |
| Farxiga Dapagliflozin Propanediol | 57 | 68 | 13 | $36K |
| Losartan Potassium Generic | 41 | 101 | 14 | $417 |
| Amlodipine Besylate Generic | 40 | 80 | 13 | $454 |
| Furosemide Generic | 33 | 65 | 16 | $138 |
| Hydralazine Hcl Generic | 24 | 46 | 13 | $263 |
| Bumetanide Generic | 22 | 28 | Under 11 | $443 |
| Chlorthalidone Generic | 20 | 28 | Under 11 | $127 |
| Spironolactone Generic | 19 | 33 | Under 11 | $105 |
| Veltassa Patiromer Calcium Sorbitex | 19 | 25 | Under 11 | $26K |
| Metoprolol Tartrate Generic | 18 | 18 | Under 11 | $121 |
| Nifedipine Er Nifedipine | 17 | 31 | Under 11 | $271 |
| Hydrochlorothiazide Generic | 15 | 27 | Under 11 | $51.12 |
| Carvedilol Generic | 15 | 19 | Under 11 | $98.21 |
| Prosol Parenteral Amino Acid 20% No.1 | 15 | 15 | Under 11 | $2,862 |
Brand drugs: 132 claims; generic drugs: 499 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit Deshpande $469 ($469 in general payments such as food, travel and fees) from 9 companies. The largest payer was Travere Therapeutics, Inc. with $114.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 3 | $114 |
| Novo Nordisk Inc NVO | 3 | $99.5 |
| Aurinia Pharma U.S., Inc. AUPH | 3 | $72.42 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $56.82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.69 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $27.17 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $24.68 |
| Ardelyx, Inc. ARDX | 1 | $24.07 |
| Vifor Pharma, Inc. | 1 | $21.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.